Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

15 results about "Bioluminescence imaging" patented technology

Bioluminescence imaging (BLI) is a technology developed over the past decade that allows for the noninvasive study of ongoing biological processes in small laboratory animals. Recently, bioluminescence tomography (BLT) has become possible and several systems have become commercially available. In 2011, PerkinElmer acquired one of the most popular lines of optical imaging systems with bioluminescence from Caliper Life Sciences.

Phage labeled array micro-fluidic chip based on dot matrix luminescence quantitative analysis, preparation method thereof and method for detecting by using bacteriophage labeled array micro-fluidic chip

The invention relates to the technical field of bacterium detection. The invention provides a bacteriophage labeled array micro-fluidic chip based on dot matrix luminescence quantitative analysis, a preparation method thereof and a method for detecting by using the same, target pathogenic bacteria are enriched by adopting magnetic beads, and specific recognition and capture of virulent strains are realized by combining an array micro-fluidic chip integrated with a bacteriophage coding probe. And after the captured viable bacteria are cracked to release ATP, bioluminescence imaging and quantitative detection are realized. The method comprises the following steps: enriching and eluting to-be-detected bacteria through magnetic beads modified with bacteriophage, then introducing a sample into an array micro-fluidic chip system, and realizing rapid qualitation and accurate quantification of live strains according to the distribution area of light-emitting signals and the number of light-emitting points in an array. The chip detection system has the characteristics of high efficiency and rapidness, can finish on-site instant detection of at most 12 food-borne pathogenic viable bacteria and virulent strains thereof within 30 minutes, and provides a new method for food safety monitoring.
Owner:GUANGDONG PHARMA UNIV

Micro / nano plastic marked based on organic long-afterglow material as well as preparation method and application of micro / nano plastic

The invention discloses a micro / nano plastic based on organic long-afterglow material labeling and a preparation method and application thereof, and belongs to the technical field of crossing of environmental science and macromolecular nano materials. According to the method, organic long-afterglow material dispersion liquid is dropwise added into micro / nano plastic dispersion liquid, and swelling is balanced; and carrying out rotary evaporation to remove the swelling agent, washing, and dialyzing until the dialysate has no obvious ultraviolet absorption, so as to obtain the micro / nano plastic marked by the organic long afterglow material. According to the method, the characteristic that the organic long-afterglow material can realize high-brightness luminescence without in-situ excitation is utilized, and the background interference of an environmental medium is effectively inhibited, so that the signal-to-noise ratio and the sensitivity of micro / nano plastic detection are remarkably improved under the environmental concentration condition. Compared with an existing marking technology, the method has the advantages that the operation is simple, the cost is low, the biocompatibility is good, and the problems of false positive interference and photobleaching can be effectively avoided; good application prospects are shown in the fields of environment migration behavior research of micro / nano plastic, bioluminescence imaging and the like.
Owner:JIANGNAN UNIV

Adjustable biological fluorescence imaging lighting device and system based on fiber bragg grating

The invention provides an adjustable bioluminescence imaging lighting device based on a fiber Bragg grating. The adjustable bioluminescence imaging lighting device comprises a light source; the first lens unit is used for converting light rays emitted by the light source into parallel light rays; the rotary light splitting unit is used for enabling all the parallel light rays to penetrate or splitting the parallel light rays into transmission light and reflected light; the second lens unit is used for transmitting the focused light and inputting the focused light to the first fiber bragg grating through the first coupler; the first fiber bragg grating is used for reflecting the narrow-band light of the first preset wave band and outputting the narrow-band light through the output end of the first coupler; the third lens unit is used for focusing the reflected light and inputting the focused reflected light to a second fiber bragg grating through a second coupler; the second fiber bragg grating is used for reflecting narrow-band light of a second preset wave band and outputting the narrow-band light through the output end of the second coupler; and the third coupler is used for mixing the input light rays of the first / second preset wave bands and then outputting the mixed light rays to the light source input end of the endoscope. The device can be used for clinical diagnosis and detection.
Owner:PROMISEMED HANGZHOU MEDITECH

A human EGFR mutation-driven mouse primary lung cancer cell line, its construction method and application

This invention belongs to the field of tumor biology and drug screening technology, specifically disclosing a human EGFR mutation-driven mouse primary lung cancer cell line, its construction method, and its applications. The cell line, ZST-1, is a human EGFR (L858R / T790M) mutation-driven lung cancer cell line derived from mouse primary lung cancer. It is stable, capable of subcutaneous tumor formation in C57BL / 6 mice, and simultaneously expresses Luciferase and tdTomato reporter genes. Its construction method includes obtaining transgenic mice, virus-induced tumor formation, continuous in vivo passage in nude mice, and in vitro culture and screening steps. This cell line can be applied to in vitro screening and efficacy evaluation of human EGFR mutation-targeting drugs, research on EGFR-TKI resistance mechanisms, tumor bioluminescence imaging and fluorescence tracing, and in vivo tumorigenesis and efficacy experiments in an immune-intact C57BL / 6 background.
Owner:ZHONGSHAN HOSPITAL FUDAN UNIV

Multimodal silica-based nanoparticles

The present invention provides a fluorescent silica-based nanoparticle that allows for precise detection, characterization, monitoring and treatment of a disease such as cancer. The nanoparticle has a range of diameters including between about 0.1 nm and about 100 nm, between about 0.5 nm and about 50 nm, between about 1 nm and about 25 nm, between about 1 nm and about 15 nm, or between about 1 nm and about 8 nm. The nanoparticle has a fluorescent compound positioned within the nanoparticle, and has greater brightness and fluorescent quantum yield than the free fluorescent compound. The nanoparticle also exhibits high biostability and biocompatibility. To facilitate efficient urinary excretion of the nanoparticle, it may be coated with an organic polymer, such as poly(ethylene glycol) (PEG). The small size of the nanoparticle, the silica base and the organic polymer coating minimizes the toxicity of the nanoparticle when administered in vivo. In order to target a specific cell type, the nanoparticle may further be conjugated to a ligand, which is capable of binding to a cellular component associated with the specific cell type, such as a tumor marker. In one embodiment, a therapeutic agent may be attached to the nanoparticle. To permit the nanoparticle to be detectable by not only optical fluorescence imaging, but also other imaging techniques, such as positron emission tomography (PET), single photon emission computed tomography (SPECT), computerized tomography (CT), bioluminescence imaging, and magnetic resonance imaging (MRI), radionuclides / radiometals or paramagnetic ions may be conjugated to the nanoparticle.
Owner:SLOAN KETTERING INST FOR CANCER RES +1

Multi-modal fusion three-dimensional imaging device and three-dimensional imaging method

The invention belongs to the technical field of biological living body imaging, and provides a multi-modal fusion three-dimensional imaging device, which comprises a first box body provided with a main camera shooting unit, an auxiliary camera shooting unit, a 3D camera shooting unit and a first light source; the second box body is arranged in the first box body; a movable first top plate is arranged on the base; the objective table is arranged in the second box body, the first top plate is located between the main camera shooting unit and the objective table, the objective table and the 3D camera shooting unit can rotate relatively, the 3D camera shooting unit and the auxiliary camera shooting unit are obliquely arranged relative to the objective table, and the first light source is used for providing a needed light source for bioluminescence imaging; the main camera shooting unit and the auxiliary camera shooting unit are used for shooting multi-angle two-dimensional bioluminescence images, the 3D camera shooting unit is used for scanning and shooting three-dimensional model contour data, the X-ray mechanism is used for shooting two-dimensional X-ray skeleton images of a measured living body, and registration is carried out through images of multiple modes, so that an accurate three-dimensional model of the measured living body is obtained.
Owner:SHANGHAI TANON LIFE SCI CO LTD

A recombinant plasmid, a recombinant lentiviral vector, a stable cell line, and a construction method and application thereof

The present invention relates to the field of biotechnology, and in particular to a recombinant plasmid, a recombinant lentivirus vector, a stably transformed cell line, and a construction method and application thereof. In the present invention, by providing a recombinant plasmid, a recombinant lentivirus, a stably transformed cell line, and a construction method and application thereof, the defects of unstable fluorescence and weak luminescence intensity existing in the bioluminescence imaging technology in the prior art are solved, and the technology has stronger hypoxia responsiveness and higher sensitivity, so that the activation level of HIF1 can be monitored, providing a new approach for the study of hypoxia response pathways related to HIF1.
Owner:XIDIAN UNIV

Fusion imaging gene and lentiviral expression plasmid, lentivirus, cell, preparation methods and applications thereof

A fusion imaging gene and lentiviral expression plasmid, lentivirus and cell, and preparation methods and applications thereof are provided. The fusion imaging gene includes bioluminescence imaging gene, fluorescent protein gene and calcium imaging gene. The three genes are linked by linkers. The fusion gene is inserted into a modified lentiviral expression plasmid to obtain lentivirus particles carrying the fusion imaging gene.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES ACADEMY OFMILITARY SCIENCES OF CHINESE PLA

Thionitrous acid near-infrared bioluminescent probe as well as preparation method and application thereof

The invention provides a thionitrous acid near-infrared bioluminescent probe and a preparation method and application thereof, the bioluminescent probe BF-5 has good selectivity, stability, biocompatibility and low detection limit (327nM), can detect physiological level HSNO in HCT116-luc cells, can be applied to bioluminescent imaging of HSNO in HCT116-luc colon cancer nude mouse transplanted tumor, and has good application prospects. The invention provides a visual detection tool for revealing the physiological and pathological mechanism of HSNO, and has important significance for researching diseases related to HSNO.
Owner:XUZHOU MEDICAL UNIVERSITY

Methods and systems for restoration and denoising of bioluminescence (BL) images

In vivo Bioluminescence Imaging (BLI) is used for longitudinal studies in small animal models across various fields, such as cancer and neuroscience. DeepBLI addresses the challenges of low photon counts and noise, which requires sensitive cameras and lengthy integration times to achieve satisfactory Signal-To-Noise Ratios (SNR) and restore spatial light distribution. The Deep Learning (DL) tool is designed to address these issues by restoring and denoising BL images using synthetic training data generated from a Poisson-Gaussian Mixture model. This tool is particularly effective in enhancing images obtained under low-level light conditions, aiding applications like kinetic imaging (KI) and Bioluminescence Tomography (BLT). DeepBLI delivers robust performance and improvement over traditional image restoration methods, making it a significant advancement in BLI technology.
Owner:KLOSE ALEXANDER +1

Bioluminescence imaging flow cytometry method and device

The present invention provides a bioluminescence imaging flow cytometry method and apparatus, comprising: a free reflection unit configured to obtain a bioluminescence signal by irradiating a sample suspension, and to re-reflect and converge the collected bioluminescence signal to enhance the detected bioluminescence signal; the sample control unit is configured to comprise a multi-channel flow type assembly, a fixing mechanism and a three-axis displacement table; the multi-channel flow type assembly is used for fixing and bearing a sample suspension, the fixing mechanism is used for fixing the multi-channel flow type assembly, and the three-axis displacement table drives the fixing mechanism to perform three-axis movement so as to adjust an imaging area of the sample suspension fixedly borne by the multi-channel flow type assembly; and an optical imaging unit configured to capture a bioluminescent cell image at a low signal level in space.
Owner:SHANDONG UNIV

Three-dimensional multi-mode accurate imaging device

The utility model relates to the technical field of medical imaging equipment, in particular to a three-dimensional multi-mode accurate imaging device. The biological optical imaging device comprises a base and an object carrying unit installed on the base, a biological optical imaging unit and a CT imaging unit are further arranged on the base, imaging paths of the biological optical imaging unit and the CT imaging unit intersect with each other, and intersection points of the imaging paths converge on a vertical center line of an object carrying station of the object carrying unit. The utility model has the advantages of simple operation and high imaging efficiency.
Owner:HEFEI RAYCISION MEDICAL TECHNOLOGY CO LTD

A microneedle patch that uses cyanin-derived pH-responsive photofunctional molecules to inhibit bacterial infection in wounds

This invention proposes a microneedle patch that seamlessly integrates infection-activated bioluminescence imaging, photodynamic therapy, and synergistic antibacterial activity with carbon monoxide gas to inhibit bacterial infection in wounds using anthocyanin-derived pH-responsive photofunctional molecules. The invention presents a high-performance phototherapy agent based on anthocyanin derivatives that can sense and dynamically adjust its fluorescence and photodynamic therapy (PDT) properties in response to changes in acidity within the infection microenvironment. Subsequently, a hydrophobic probe is co-assembled with a reactive oxygen species (ROS) CO donor to form a biocompatible therapeutic nanosystem, which is further encapsulated in a hyaluronic acid microneedle patch to enhance its mechanical penetration and controlled-release activity at the infection site. The binding of PDT with the CO gas cascade produces a powerful bacterial elimination effect, significantly inhibiting bacterial biofilm-mediated infection. This ingenious combination of infection-activated bioimaging and synergistic antibacterial therapy offers significant potential for the effective and personalized management of infection-related diseases.
Owner:CHANGCHUN UNIV OF TECH +2

A sulfonitroso near-infrared bioluminescent probe and a preparation method and application thereof

This invention provides a near-infrared bioluminescent probe of thionitrite, its preparation method, and its application. The bioluminescent probe BF-5 has good selectivity, stability, biocompatibility, and a low detection limit (327 nM). It can detect the physiological level of HSNO in HCT116-luc cells and can be applied to bioluminescent imaging of HSNO in HCT116-luc colon cancer xenografts in nude mice. It provides a visual detection tool for revealing the physiological and pathological mechanisms of HSNO and is of great significance for studying diseases related to HSNO.
Owner:XUZHOU MEDICAL UNIVERSITY

A phage labeled array microfluidic chip based on quantitative analysis of dot array light emission, a preparation method thereof and a detection method using the same

ActiveCN120888391BMagnetic beadLight emission
The present application relates to the technical field of bacterial detection. The present application provides a phage-labeled array microfluidic chip based on quantitative analysis of dot array luminescence, a preparation method thereof and a detection method using the same. The target pathogenic bacteria are enriched by magnetic beads, and the array microfluidic chip integrated with phage coding probes is combined to realize specific recognition and capture of strong strains. After the captured live bacteria are lysed to release ATP, bioluminescence imaging and quantitative detection are realized. The process is as follows: the bacteria to be tested are enriched and eluted by magnetic beads modified with phages, then the sample is introduced into the array microfluidic chip system, and according to the distribution area and the number of luminescent points in the array, rapid qualitative and accurate quantitative detection of live strains can be realized. The chip detection system has the characteristics of high efficiency and rapidness, and can complete on-site real-time detection of up to 12 kinds of foodborne pathogenic live bacteria and their strong strains within 30 minutes, thereby providing a new method for food safety monitoring.
Owner:GUANGDONG PHARMA UNIV